New HIV Integrase Inhibitors Findings from Stanford University Discussed (Treatment Emergent Dolutegravir Resistance Mutations In Individuals Naïve To Hiv-1 Integrase Inhibitors: a Rapid Scoping Review).
In: Drug Week, 2023-11-10, S. 1780-1780
serialPeriodical
Zugriff:
Keywords: Stanford; State:California; United States; North and Central America; Dolutegravir Therapy; Drug Resistance; Drugs and Therapies; Enzymes and Coenzymes; HIV Integrase Inhibitors; Health and Medicine; Integrases; Pharmaceuticals; Recombinases EN Stanford State:California United States North and Central America Dolutegravir Therapy Drug Resistance Drugs and Therapies Enzymes and Coenzymes HIV Integrase Inhibitors Health and Medicine Integrases Pharmaceuticals Recombinases 1780 1780 1 11/06/23 20231110 NES 231110 2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Drugs and Therapies - HIV Integrase Inhibitors. New HIV Integrase Inhibitors Findings from Stanford University Discussed (Treatment Emergent Dolutegravir Resistance Mutations In Individuals Naïve To Hiv-1 Integrase Inhibitors: a Rapid Scoping Review) For more information on this research see: Treatment Emergent Dolutegravir Resistance Mutations In Individuals Naïve To Hiv-1 Integrase Inhibitors: a Rapid Scoping Review. [Extracted from the article]
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
New HIV Integrase Inhibitors Findings from Stanford University Discussed (Treatment Emergent Dolutegravir Resistance Mutations In Individuals Naïve To Hiv-1 Integrase Inhibitors: a Rapid Scoping Review).
|
---|---|
Zeitschrift: | Drug Week, 2023-11-10, S. 1780-1780 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6440 (print) |
Sonstiges: |
|